Longer-term prospective and randomized studies are needed to confirm the durability of weight loss, clarify differential metabolic effects, and evaluate long-term cardiovascular and hepatic outcomes in treatment-nave populations
ProRx is not the only 503B facility to receive a warning letter or issue a recall
In addition, the following symptoms may indicate a medical emergency and require immediate evaluation: Sudden severe pain in the lower back, abdomen, or legs Severe vomiting, diarrhea, or dehydration Very low blood pressure or loss of consciousness These are not features of typical Adrenal Fatigue
Lyophilized peptides should be stored at -20C
While most clinical trials of AOMs focus on measuring weight loss alone, the effect of AOMs on lean body mass was reported in a number of trials, which found that lean mass accounted for 15-45% of total weight loss (see Figure 1)
But one study did compare the effects of body weight when used to treat type 2 diabetes